TrialAnnals of the rheumatic diseases2023

Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.

Robert B M Landewé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.